Prof, David Planchard, MD, PhD
Thoracic Oncologist
Head of the Thoracic Group at Institut Gustave Roussy (IGR), Villejuif, FRANCE
President of the International Centre for Thoracic Cancers (CICT), a health cooperation group combining Gustave Roussy, the Marie-Lannelongue Hospital and the Paris Saint-Joseph Hospital.
Pr Planchard’s primary research interests have focused on immunotherapy, genomic analysis and biomarkers and targeted treatments of lung cancers over the last 20 years of his career. He has been involved in more than 200 phase I, II and III clinical trials, with over 250 published articles.
He has been directly involved in trial design, having been international coordinating investigatoir on trials in the field of thoracic tumours, with the aim to develop a long-term clinical research strategy based on molecular screening.
Pr Planchard participated the latest european recommendations on the management of metastatic non-small-cell lung cancer (ESMO guidelines) and participated in many national and international conferences including ESMO (European Society for Medical Oncology), ELCC (European Lung Cancer Congress), ASCO (American Society of Clinical Oncology) and WCLC (World Conference of Long Cancer).